The Na ϩ /K ϩ ATPase (NKA) is an essential membrane protein underlying the membrane potential in excitable cells. Transmembrane ion transport is performed by the catalytic ␣ subunits (␣1-4). The predominant subunits in neurons are ␣1 and ␣3, which have different affinities for Na ϩ and K ϩ , impacting on transport kinetics. The exchange rate of Na ϩ /K ϩ markedly influences the activity of the neurons expressing them. We have investigated the distribution and function of the main isoforms of the ␣ subunit expressed in the mouse spinal cord. NKA␣1 immunoreactivity (IR) displayed restricted labeling, mainly confined to large ventral horn neurons and ependymal cells. NKA␣3 IR was more widespread in the spinal cord, again being observed in large ventral horn neurons, but also in smaller interneurons throughout the dorsal and ventral horns. Within the ventral horn, the ␣1 and ␣3 isoforms were mutually exclusive, with the ␣3 isoform in smaller neurons displaying markers of ␥-motoneurons and ␣1 in ␣-motoneurons. The ␣3 isoform was also observed within muscle spindle afferent neurons in dorsal root ganglia with a higher proportion at cervical versus lumbar regions. We confirmed the differential expression of ␣ subunits in motoneurons electrophysiologically in neonatal slices of mouse spinal cord. ␥-Motoneurons were excited by bath application of low concentrations of ouabain that selectively inhibit NKA␣3 while ␣-motoneurons were insensitive to these low concentrations. The selective expression of NKA␣3 in ␥-motoneurons and muscle spindle afferents, which may affect excitability of these neurons, has implications in motor control and disease states associated with NKA␣3 dysfunction.
Introduction
The Na ϩ /K ϩ ATPase (NKA) is ubiquitously expressed in membranes and maintains ionic gradients through the antiport of Na ϩ and K ϩ ions. Transmembrane ion transport is performed by the catalytic ␣ subunit, of which there are 4 isoforms (␣1-4). These isoforms have different kinetic properties (Segall et al., 2001 ) and very specific tissue distributions (for review, see Sweadner, 1989) , with potential impact on control of neuronal function. The predominant CNS subunits are the ␣1, ␣2, and ␣3 subunits (Sweadner, 1989; Viola and Rodríguez de Lores Arnaiz, 2007) . The ␣1 and ␣3 subunits appear to be the most prominently expressed in neurons (Mata et al., 1991; Watts et al., 1991) , but their expression patterns are not fully elucidated.
Understanding the expression patterns of the different isoforms of NKA␣ subunits has clinical implications. Two movement disorders are caused by different missense mutations in the ATP1A3 gene encoding the ␣3 subunit of the Na ϩ /K ϩ -ATPase (NKA␣3): Alternating Hemiplegia of Childhood (AHC, OMIM #614820), characterized by episodes of transient hemiplegia/ hemiparesis, dystonia and choreoathetosis (Heinzen et al., 2012; Rosewich et al., 2012; Kirshenbaum et al., 2013) , and RapidOnset Dystonia-Parkinsonism (RDP, dystonia 12, OMIM #128235), characterized by abrupt onset of dystonia with parkinsonism after a stressful event, typically in late adolescence or early adulthood (Brashear et al., 1998; de Carvalho Aguiar, 2004; Brashear et al., 2007) . The pathophysiology of RDP differs from dystonia and Parkinson's disease since L-DOPA treatment (Brashear et al., 2007) and deep brain stimulation of the basal ganglia (Deutschländer et al., 2005) have little or no therapeutic effect. Poor responses to these therapies suggest that dysfunction in motor circuits outside the basal ganglia contribute to RDP symptoms. Since the common mutation underlying these two movement disorders is in the NKA␣3 subunit and given that the final common pathway for motor control is through neuronal circuitry in the spinal cord, the expression pattern of this and other NKA subunits in these spinal cord circuits may be of critical importance in understanding these pathologies.
Within the spinal cord, there is controversy regarding the specific distribution of the ␣1 subunit with suggestions using immunohistochemistry that it is limited to glial cells in the ventral white matter and absent from the gray matter entirely (McGrail et al., 1991) , whilst in situ hybridization suggests that it is present within motoneurons and not in glia (Mata et al., 1991; Watts et al., 1991; Sayers et al., 1994) . The ␣3 subunit may have a more widespread distribution, being observed within all neurons of the spinal cord including the motoneurons reported to express ␣1 (Mata et al., 1991) . It is important to resolve the tissue distribution of these isoforms and determine whether they are coexpressed within single populations of cells.
We show that NKA␣ subunits have a mutually exclusive expression within ␣-and ␥-motoneurons that may represent a novel therapeutic avenue for pathologies involving motoneuron dysfunction. Furthermore, these data reveal how NKA␣3 loss-offunction mutations could contribute to dysfunction in spinal circuitry and thus the motor symptoms of AHC and RDP.
Materials and Methods
All procedures were performed in accordance with the UK Animals (Scientific Procedures) Act 1986. Immunohistochemistry. Tissue from young adult wild-type C57BL/6 mice of either sex (6 d old, n ϭ 3; 6 -8 weeks old, n ϭ 12) was prepared for immunohistochemistry as previously described (Edwards et al., 2007) . Motor, preganglionic, and sensory neurons were labeled by intraperitoneal injection of hydroxystilbamidine (Fluorogold, FG, 0.1 ml of 1% i.p. in H 2 O, Fluka, BioChemika) 3 d before perfusion. Before primary antibody incubation, tissue sections were incubated in 10 mM sodium citrate at 70°C for 20 min. All primary antibody incubations were performed overnight at 4°C in PBS containing 0.1% Triton X-100 and secondary antibody incubations were performed at room temperature in PBS for 1-3 h (Invitrogen Alexa Fluor secondaries) or 4 h (Jackson ImmunoResearch biotinylated secondaries).
Tissue sections were incubated with rabbit anti-NKA␣3 (1:500 -1000; Millipore Biotechnology), or mouse anti-NKA␣3 (1:1000; Affinity Bioreagents) and detected using donkey anti-rabbit Alexa Fluor 555 (1: 1000, Invitrogen) or donkey anti-mouse Alexa Fluor 488 (1:1000, Invitrogen) as appropriate. NKA␣1 was detected with monoclonal antibodies raised in rabbit (Epitomics, 2047-1, 1:1000) or mouse (DSHB, 6F, 1:100), visualized with Alexa Fluor-conjugated secondary antibodies appropriate to double labeling protocols.
Western blotting. Protein extraction and blot analysis. Membrane protein fractions were isolated from frozen spinal cord and brain tissue from C57BL/6 mice using a ProteoJET Membrane Protein Extraction Kit (Fermentas) according to the manufacturer's instructions. Twenty-four micrograms of each membrane extract, determined by Bradford assay (Protein Assay, Bio-Rad), were incubated at 37°C for 15 min, subjected to gradient SDS-PAGE (100 V, 1.5 h) in 4 -15% Mini-PROTEAN TGX Gels (Bio-Rad) in parallel with 5 l Precision Plus Protein Standard (BioRad), and then blotted (100 V, 2 h) onto PVDF membrane (Pall). After blocking with 5% milk in PBS-T (PBS, 0.1% Tween-20) overnight, membranes were incubated for 2 h with rabbit anti-NKA ␣1 (Epitomics; 1:10,000) or rabbit anti-NKA ␣3 (06 -172; Millipore; 1:1000). Immune complexes were detected by chemiluminescence (Novex ECL, Invitrogen) with HPR-conjugated chicken anti-rabbit (Santa Cruz Biotechnology; 1:2000) . Protein bands were visualized by exposing the membranes to photographic film for 30 s.
Anti-NKA antibody specificity. Western blots of mouse brain and spinal cord using the rabbit anti-NKA␣1 antibody, raised against an N-terminal peptide sequence unique to the ␣1 isoform, detected a single band with a molecular weight of ϳ100 kDa (Fig. 1) , consistent with the molecular weight of this isoform in rat brain preparations (Shyjan and Levenson, 1989) . We further confirmed the specificity of antibody staining for NKA␣1 using the monoclonal antibody 6F (DSHB). This antibody (6F) has previously been indicated to be specific to NKA␣1 by extensive Western blotting and epitope mapping in several tissues of different species, where it was also shown that it did not cross react with NKA␣2 or NKA␣3 (Arystarkhova and Sweadner, 1996) .
The Millipore antibody to NKA␣3 (raised against a fusion protein of amino acids 320 -514 of the NKA␣3) has been extensively characterized as specific previously, where Western blotting showed that it detected a single protein of ϳ100 kDa corresponding to the molecular weight of the ␣ subunit of NKA in lysate from whole brain or neurons (Shyjan and Levenson, 1989) . Western blots of brain and spinal cord revealed a single band with a molecular weight of ϳ100 kDa from both tissues (Fig. 1) . The mouse anti-NKA␣3 antibody (Affinity Bioreagents, clone XVIF9-G10) detects a sequence within 50 aa of the N terminus as shown by epitope mapping and its lack of reactivity with NKA␣1 and NKA␣2 and specificity has previously been shown by Western blotting (Arystarkhova and Sweadner, 1996) .
Neurochemical characterization. To detect motoneurons, double labeling was performed using goat anti-choline acetyltransferase (ChAT; 1:500, AB144P, Millipore), which was visualized using donkey anti-goat Alexa Fluor 488 (1:1000, Invitrogen). To distinguish between ␣-and ␥-motoneurons, ␣3 and ChAT immunohistochemistry were combined with staining for NeuN, which is absent from ␥-motoneurons (Friese et al., 2009), using mouse anti-NeuN (1:1000, Clone A60, Millipore), detected using biotinylated secondary antibodies (donkey anti-mouse 1:250, Jackson ImmunoResearch) and streptavidin Pacific Blue (1:1000 in PBS, Invitrogen).
To determine whether ␣3 was found within the large muscle spindle afferent neurons, double labeling was performed upon 50 m sections of dorsal root ganglion (DRG) for parvalbumin (Pv; mouse anti-Pv, 1:1000, P3088, Sigma).
Tissue was then prepared for viewing using a Nikon E600 epifluorescent microscope and Acquis image capture system (Synoptics) or an Inverted Zeiss LSM510 confocal microscope.
Electrophysiology. Spinal cord slices from neonatal mice (6 -11 d, n ϭ 10 mice) were prepared as previously described for rats (Wang et al., 2008) . Whole-cell current-clamp recordings were made from large ventral horn neurons. Through the addition of tetramethylrhodamine and neurobiotin to the intracellular solution, recorded neurons were confirmed as motoneurons upon post hoc analysis of their morphology. Neurons were held at ϳϪ60 mV and characterized by injection of rectangular hyperpolarizing and depolarizing current pulses of Ϫ300 to ϩ500 pA (1 s duration). Data analysis was performed off line. To further distinguish between ␣-and ␥-motoneurons, recorded cells were tested for their sensitivity to the 5HT-1D agonist L694247, the receptor for which is selectively expressed in ␥-motoneurons (Enjin et al., 2012 ). All cells were tested for responses to 3 M ouabain, a cardiac glycoside that inhibits NKA␣3 in the nM-M range (Urayama and Sweadner, 1988) . Cells that did not respond to 3 M ouabain were then tested with 30 M ouabain to reveal responses mediated by NKA␣1.
Statistical analysis. All data are presented as mean Ϯ SEM, and significance was set at p Ͻ 0.05. For immunohistochemistry experiments, n refers to the number of animals and N refers to the number of cells counted; for electrophysiological experiments, n refers to the number of cells recorded. For both immunohistochemical and electrophysiological data, significance was tested using unpaired Student's t test to examine differences between ␣-and ␥-motoneurons.
Results
Distribution of NKA␣1 in the spinal cord NKA␣1 immunoreactivity was observed in cervical, thoracic, and lumbar spinal cord sections (n ϭ 7, Fig. 2A-A2 ). NKA␣1 immu- noreactivity (IR) was found within putative presynaptic structures within the superficial layers of the dorsal horn (Fig. 2B) . The ependymal cells surrounding the central canal (CC) were strongly immunopositive for NKA␣1 (Fig. 2C ), as were neurons in the ventral horn (Fig. 2D ). In the lateral horn, NKA␣1-IR was visible in the membranes of neurons (Fig. 2A1 ) that were identified as sympathetic preganglionic neurons as they were also choline acetyltransferase (ChAT) positive (data not shown). The pattern of staining did not differ between 6 d (the age at which electrophysiology is performed) and 6 -8 weeks (Fig. 2E-G) .
Distribution of NKA␣3 in the spinal cord
NKA␣3-IR was also observed throughout the spinal cord at cervical, thoracic, and lumbar levels (n ϭ 12, Fig. 3A-A2 ). All areas of the spinal cord displayed immunoreactivity for NKA␣3. However, upon closer examination, it was observed that this NKA␣ isoform is not ubiquitously expressed; rather, NKA␣3-IR was concentrated in the membranes of some cells and absent from others. This was particularly clear within lamina X of the spinal cord, where NKA␣3-IR could be seen in the membranes of small to medium sized neurons but was absent from ependymal cells (Fig. 3C ). In the dorsal horn, the larger neurons within this region were also NKA␣3-immunonegative, although surrounded by NKA␣3-IR punctate structures (Fig. 3B ). This pattern was observed again in the ventral horn, where many cells were immunoreactive for NKA␣3, but approximately two thirds of the large cells (presumed ␣-motoneurons) were devoid of immunoreactivity (Figs. 3D, 4) . Again, the pattern of staining was not different between the two ages studied (Fig. 3E-G ).
NKA␣1 and NKA␣3 subunits are found within distinct populations of motoneurons in the ventral horn Ventral horn motoneurons, identified through immunoreactivity for ChAT (Fig. 4A2 ) and retrograde tracing from the periphery with Fluorogold (Fig. 4A3) , were immunopositive for either the NKA␣1 OR the NKA␣3 subunit but never both and this selectivity correlated with soma size (Fig. 4A-A4) . Specifically, the NKA␣1-immunopositive motoneurons were significantly larger than those that expressed the NKA␣3 subunit (NKA␣1-IR 1439 Ϯ 89 m 2 , N ϭ 91 vs NKA␣3-IR 333 Ϯ 16 m 2 , N ϭ 48, n ϭ 5; Fig. 4A5 , p Ͻ 0.001). The separation of the expression of either NKA␣1 or NKA␣3 on the basis of size suggests that the NKA␣1 subunit is found within ␣-motoneurons and that NKA␣3 subunit is expressed by ␥-motoneurons. To confirm that the small NKA␣3-IR motoneurons were ␥-motoneurons, we assessed the expression of NeuN in conjunction with immunohistochemistry for the two NKA␣ isoforms. NeuN is found within ␣-motoneurons but is absent from ␥-motoneurons (Friese et al., 2009). NeuN expression was absent from NKA␣3-IR motoneurons, confirming them as ␥-motoneurons (Fig. 4B-B3 ).
NKA␣3 subunits are also found within the sensory components of the fusimotor system
We next determined whether the NKA␣3 subunit was expressed in the muscle spindle afferents that make up the sensory part of the fusimotor system. Consistent with previous findings, NKA␣3-IR was only observed in a subpopulation of dorsal root ganglion neurons (Dobretsov et al., 1999; . Interestingly, there appeared to be significantly more NKA␣3-IR neurons in cervical DRG (C4, 73.1 Ϯ 5.0%, N ϭ 311/433, n ϭ 7) than in lumbar (L2, 17.2 Ϯ 2.8%, N ϭ 131/773, n ϭ 6, p ϭ 0.00002). At both lumbar and cervical levels, the NKA␣3-IR neurons were large and double-labeling for parvalbumin (Pv), a marker for muscle sensory afferents (Arber et al., 2000; Ichikawa et al., 2004; Mentis et al., 2006) (Fig. 3H-H2 ), revealed that without exception, all NKA␣3-IR neurons were also Pv-IR. To confirm further that these sensory neurons were muscle spindle afferents, we performed immunohistochemistry for NKA␣3 on muscle sections, in which clear NKA␣3-IR was found throughout the membrane of the spindle afferent wrapping around the intrafusal muscle fiber but not within the fiber itself (N ϭ 17, n ϭ 4; Fig. 3I ).
Low concentrations of ouabain depolarized ␥-motoneurons
but not ␣-motoneurons, suggesting that functional NKA␣3 subunits are limited to ␥-motoneurons Whole-cell patch-clamp recordings were undertaken in mouse spinal cord slices. Large neurons in the ventral horn, targeted as putative motoneurons, were filled with rhodamine and neurobiotin and confirmed as such post hoc (Fig. 5 A, B) . Motoneurons typically had a large soma, an axonal projection heading ventrally toward the edge of the gray matter and a multipolar arrangement of dendrites. Discrimination of ␣-and ␥-motoneurons based solely on their size is not appropriate at this age, since there is a high degree of overlap between the cell cross-sectional areas of the two classes of motoneuron (Shneider et al., 2009) , and was therefore not used as a factor to differentiate between the two classes. Motoneurons had very low input resistance in keeping with their large somatic size, and a high rheobase. On the basis of their responses to hyperpolarizing and depolarizing current pulses, motoneurons were putatively split into ␣ (n ϭ 5) and ␥ (n ϭ 8) subtypes. Consistent with previous reports (Enjin et al., 2012), ␥-motoneurons had a higher input resistance than ␣-motoneurons (180 Ϯ 52 vs 78 Ϯ 15 M⍀, p Ͻ 0.05). ␣-Motoneurons also displayed a more negative action potential threshold than that observed in ␥-motoneurons (Ϫ43.4 Ϯ 1.9 vs Ϫ31.8 Ϯ 4.6 mV, p Ͻ 0.05) and a longer action potential duration (4.9 Ϯ 0.6 vs 3.5 Ϯ 0.3 ms, p Ͻ 0.05). There were no significant differences observed in the resting membrane potential of the ␣-and ␥-motoneurons (Ϫ56.3 Ϯ 2.7 vs Ϫ61.6 Ϯ 0.6 mV, respectively), the action potential amplitude (57.7 Ϯ 6.1 vs 56.4 Ϯ 5.2 mV), the amplitude of the after-hyperpolarization (4.7 Ϯ 1.7 vs 3.8 Ϯ 0.7 mV), the rheobase for generating action potentials (236.2 Ϯ 84.2 vs 344.4 Ϯ 98.0 pA), nor the delay to action potential generation at rheobase (140.1 Ϯ 72.2 vs 169.6 Ϯ 32.6 ms). Typical responses to hyperpolarizing and depolarizing current pulses are shown in Figure 5 , A1 (␣-motoneuron) and B1 (␥-motoneuron).
The classification of recorded motoneurons as ␣-or ␥-motoneurons was ratified through bath application of the 5HT1D agonist L694247 at 10 M (Enjin et al., 2012 ). L694247 evoked a robust depolarization of 15.5 Ϯ 1.7 mV from Ϫ60 mV (n ϭ 7) in those neurons classified as ␥-motoneurons, but had no effect on those classified as ␣-motoneurons (change in membrane potential of Ϫ2.4 Ϯ 2.7 mV, n ϭ 5; Fig. 5A2,B2 ).
There was a highly significant difference between ␣-and ␥-motoneurons ( p Ͻ 0.001) in their response to 3 M ouabain [which would strongly inhibit NKA␣3 as it has an IC50 for ouabain of ϳ6.7 nM, but not inhibit NKA␣1-IC50 for ouabain is 38 M (O'Brien et al., 1994)], with ␥-motoneurons displaying a clear depolarization (9.4 Ϯ 0.9 mV, time to peak 311.6 Ϯ 74.0 s, n ϭ 8) and ␣-motoneurons displaying no change in their membrane potential (Ϫ0.55 Ϯ 1.4 mV, n ϭ 5; Fig. 5A3,B3 ). There were also significant differences in the response of ␣-and ␥-motoneurons to 30 M ouabain (which, based on the IC50 values above, would strongly inhibit NKA␣3 and would inhibit NKA␣1 to a lesser extent). ␣-Motoneurons depolarized by 11.4 Ϯ 0.5 mV to bath application of 30 M ouabain (n ϭ 5), while ␥-motoneurons displayed a greater depolarization of 15.5 Ϯ 1.7 mV (n ϭ 3, p Ͻ 0.05; Fig. 5A4,B4) . The response to 30 M ouabain in ␣-motoneurons was also slower than that observed in ␥-motoneurons (time to peak 293.7 Ϯ 71.5 vs 136.5 Ϯ 26.0 s, p Ͻ 0.05). Group data for drug responses is summarized in Figure 5C .
Discussion
This study applies both immunohistochemistry and electrophysiology to explore the distribution of NKA␣1 and NKA␣3 subunits in motoneurons of the spinal cord. Strikingly, the subunits are differentially expressed in motoneurons, as the NKA␣1 is present in ␣-motoneurons, whereas the NKA␣3 is restricted to ␥-motoneurons. Furthermore, consistent with a primary role on proprioception in the motor system, NKA␣3 is also present in parvalbumin-positive sensory neuron somata and sensory endings in the muscle spindle. Electrophysiological recordings from ventral horn motoneurons confirm the presence of NKA␣3 in ␥-motoneurons and NKA␣1 in ␣-motoneurons.
We report a widespread localization of NKA␣3 in the spinal cord but it appears absent from ␣-motoneurons. The restriction of NKA␣3 to ␥-motoneurons is consistent with immunostaining of ventral roots, where NKA␣3 immunoreactivity is only found in the smaller caliber axons, and also staining of muscle where NKA␣3 is found in end plates on intrafusal muscle fibers . Here, we also show that NKA␣1 is expressed prominently in large ventral horn neurons. These we have defined as ␣-motoneurons on the basis of their expression of ChAT and NeuN (Friese et al., 2009) . To functionally confirm the differential distribution of NKA␣1 and NKA␣3 subunits to ␣-and ␥-motoneurons, respectively, we exploited the differing sensitivity of these isozymes to the cardiac glycoside ouabain. Only motoneurons sensitive to the 5HT1D agonist L694247 also (A, B) and their basic electrophysiological responses to depolarizing and hyperpolarizingcurrentpulses(A1,B1).Cellswereconfirmedaseither␣-or␥-motoneuronsbaseduponand their response to the 5HT1D agonist L694247 (10 M, A2 and B2, n ϭ 5 and 8, respectively). ␥-Motoneurons, which responded to L694247, also responded to 3 M ouabain (B3, n ϭ 8) and 30 M ouabain (B4, n ϭ 3). ␣-Motoneurons, which did not respond to L694247, did not respond to 3 Mouabain(A3,nϭ5)butdidrespondto30Mouabain(A4,nϭ5).Groupdatacomparingthese responses is shown in C, black bars ϭ ␣-motoneurons and white bars ϭ ␥-motoneurons. *p Ͻ 0.05, **p Ͻ 0.01, ***p Ͻ 0.005. responded to a low micromolar concentration of ouabain, consistent with the specific localization of the NKA␣3 subunit to ␥-motoneurons. Motoneurons which were insensitive to L694247 did, however, respond to a much higher concentration of ouabain, sufficient to inhibit the NKA␣1 subunit. This demonstrates a clear difference in the sensitivity of ␣-and ␥-motoneurons to exogenously applied ouabain, consistent with the differential expression of NKA␣ subunits.
We found that NKA␣3-IR cells had smaller somata than NKA␣1-IR cells, consistent with previous studies that ␥-motoneurons have smaller soma size than ␣-motoneurons (Strick et al., 1976; Westbury, 1982) . Furthermore, NKA␣3-IR motoneurons did not express NeuN, another property that differentiates ␥-motoneurons from ␣-motoneurons (Friese et al., 2009) . Thus, NKA␣3 expression can be added to the growing markers that can be used to differentiate ␥-motoneurons from ␣-motoneurons, such as ERR3 (Friese et al., 2009) and GDNF (glial cell line-derived neurotrophic factor) receptor subunit GFR␣1 (Shneider et al., 2009 ) and 5HT 1D receptors (Enjin et al., 2012) .
We found the NKA␣3 subunit expressed within parvalbuminpositive sensory neurons and muscle spindle sensory endings, previously linked with proprioceptive functions (Dobretsov, 2003; . We also noted that the proportion of NKA␣3-expressing neurons is higher in cervical DRG than in lumbar. This indication that there is a higher proportion of cervical DRG neurons with potential proprioceptive function than lumbar DRG neurons is supported by the observation that up to 65% of cervical DRG neurons project to the dorsal column nuclei compared with15% of lumbar DRG neurons in the rat (Giuffrida and Rustioni, 1992) . Although it must be noted that not all dorsal column nuclei projecting neurons are involved in proprioception, these proportions tally well with those of the NKA␣3-positive sensory neurons in this study. Presumably, this increased proprioceptive traffic at cervical levels reflects high levels of dexterity and degrees of movement in the hands, forelimbs, and high muscle spindle content of neck muscles (Richmond and Abrahams, 1975; Kulkarni et al., 2001) .
The physiological relevance of selective expression of NKA␣ subunits in neurons remains to be fully determined. However, the NKA␣3 subunit is able to extrude Na ϩ ions that accumulate intracellularly during action potential firing at a faster rate than NKA␣1, which supports higher firing rates of neurons (Azarias et al., 2013) . This is consistent with higher firing rates observed in ␥-motoneurons than ␣-motoneurons both in vivo (Ellaway and Murphy, 1981) and in vitro [here and the study by Enjin et al. (2012) ]. The selective expression of NKA␣3 in muscle spindle afferents peripherally is likely to be of further physiological importance, placing this exquisitely ouabain-sensitive form of the NKA throughout the fusimotor system. This system is thus likely to be selectively and tonically influenced by the adrenocortically produced hormone known as endogenous ouabain (EO), present in the circulation in the nanomolar range (Harwood and Yaqoob, 2005) , which is sufficient to inhibit NKA␣3 rather than NKA␣1. As low concentrations of ouabain increased firing rates of ␥-motoneurons in spinal cord slices, both spindle afferents and ␥-motoneurons are likely to be more excitable in vivo due to EO. Since there is a paucity of information on the firing properties of ␥-MNs in the spinal cord in vivo, these current data reveal a mechanism through which the excitability of ␥-MNs can be regulated differentially to that of ␣-MNs.
Indeed, the loss of function mutation of NKA␣3 in the movement disorders AHC and RDP (de Carvalho Aguiar, 2004; Brashear et al., 2007; Heinzen et al., 2012; Rosewich et al., 2012; Kirshenbaum et al., 2013) exaggerates the outcomes of NKA␣3 inhibition that may be normally undertaken by EO. Current understanding of RDP suggests that the loss of function of NKA␣3 in the basal ganglia and cerebellum underlies the symptoms of the disease, as dual perfusion of ouabain into these areas of the mouse brain mimics much of the phenotype of the disease (Calderon et al., 2011) . Our results suggest an additional contribution to motor symptoms of AHC and RDP from dysfunction in spinal sensorimotor circuits. The loss of function mutations in NKA␣3 may cause the affected spindle afferents and ␥-motoneurons to exist in a more depolarized state and thus increase their excitability. In turn, it is then feasible that this would have an indirect effect upon the excitability of the ␣-motoneurons.
In conclusion, we have revealed specific distributions of the ␣1 and ␣3 subunits of NKA throughout the spinal cord. The difference in the distribution of these isoforms is highlighted in the ventral horn, where the NKA␣1 subunit is found within ␣-motoneurons and the NKA␣3 subunit within ␥-motoneurons. Electrophysiological experiments confirmed the mutually exclusive distribution of the NKA␣ subunits in motoneurons. Such differential distribution has consequences for physiological function of sensorimotor circuits and may contribute to symptoms of pathophysiological mutations in NKA␣3.
